system that protect patients. >> the gentleman from california. >> thank you, mr. chairman. i want to commend the congressman for his questions. we need to correct the law before the end of this year for this simple reason beginning next year, some of these interest groups will gear up to stop legislation. we do not need to have the fda to look at these compounders. they will be regulated but the state level. you are being criticized, dr. hamburg as the head of the fda, for the problems that were primarily the responsibility of the state of massachusetts, and often we hear that we should let the states handle things and not the federal government. i want to express some sympathy for you at the fda because you are in a no-win situation. the agency is accused of being a job killer, and over- regulator, and now when something terrible happens, we hear that something went wrong, and everybody is quick to jump on you for not doing enough now, if we expect you to do more, -- enough. now, if we expect you to do more we have to be sure the statutory law gives you enough to do your job. let
